Page 26 - Relapse News Today

Treatment that can be considered in itself as a new disease. so thats why you want to identify the patients that are not likely to relapse. owkin aims to complement everyday clinical practice with its tool. it can already be used in european hospitals and the companys working on an updated version for those in the uk. what does an oncologist whos used to having difficult conversations with patients make of it, though? what we do now, in terms of assessment of the risk, is to have the standard in...

Be able to... to get rid of the disease. in these patients, we want to avoid as much as possible an over—treatment that can be considered in itself as a new disease. so thats why you want to identify the patients that are not likely to relapse. 0wkin aims to complement everyday clinical practice with its tool. it can already be used in european hospitals, and the company is working on an updated version for those in the uk. what does an oncologist, whos used to having difficult conversations w...

Here, you have the breast cancer_ here, you have the breast cancer that you can see. the thing — cancer that you can see. the thing that— cancer that you can see. the thing that is why it is fat tissue _ thing that is why it is fat tissue and the cancer is all this— tissue and the cancer is all this stuff_ tissue and the cancer is all this stuff which is kind of purple _ this stuff which is kind of purple. i_ this stuff which is kind of purple. i can see all of these details — purple. i ...

In these patients, we want to avoid as much as possible a heavy treatment that can be considered in itself as a new disease. so thats why you want to identify the patients that are not likely to relapse. 0kin aims to complement everyday clinical practice with its tool. it can already be used in european hospitals, and the companys working on an updated version for those in the uk. what does an oncologist whos used to having difficult conversations with patients make of it, though? what we do now...

An over—treatment that can be considered in itself as a new disease. so thats why you want to identify the patients that are not likely to relapse. 0wkin aims to complement everyday clinical practice with its tool. it can already be used in european hospitals, and the company is working on an updated version for those in the uk. what does an oncologist, whos used to having difficult conversations with patients, make of it, though? what we do now in terms of assessment of the risk is to have th...

French and us tech company 0kin has partnered with the hospital to digitise over 1,500 tissue samples from women with breast cancer. this will provide some of the information needed to classify patients between having a high, intermediate or low risk of their disease returning within five years. we know that for this type of cancer, the prognosis is good, with more than 90% of patients being able to get rid of the disease. in these patients, we want to avoid as much as possible a heavy treatment...

Treatment that can be considered in itself as a new disease. so, thats why you want to identify the patients that are not likely to relapse. 0wkin aims to complement everyday clinical practice with its tool. it can already be used in european hospitals and the companys working on an updated version for those in the uk. what does an oncologist whos used to having difficult conversations with patients make of it, though? what we do now in terms of assessment of the risk is to have the standard inf...

AXS-05 statistically significantly delayed time to relapse of Alzheimer’s disease agitation versus placebo AXS-05 statistically significantly prevented relapse of Alzheimer’s disease... | November 28, 2022

Colon cancer is the third most common disease in the world, with more than 2 million new cases diagnosed each year

Researchers at Uppsala University have discovered a certain protein that makes tumour cells resting and insensitive to radiation treatment.